Delivery Order SPE2DB22D2005-SPE2DB25FJTH7
Award Date 9/22/25
Potential Completion Date 10/14/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ibrance 125 mg tablets in a 7-tablet configuration. This contract, valued at $8,118.08 with a firm fixed price structure, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ibrance 75 mg tablets in quantities of seven units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $8,123.96 and is scheduled for completion by September 26, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ibrance 100 mg tablets in 7-count packaging, with a contract ceiling value of $24,367.44 and completion date of October 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The place of...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ibrance 100 mg tablets in quantities of seven units. This firm fixed price delivery order, valued at $32,489.92, represents a competitive award with no set-aside designation and is scheduled for completion by September 24, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-count), valued at $8,122.48 under a firm fixed price contract. This non-set-aside delivery order is scheduled for completion by September 3, 2025, with performance of work occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a $8,118.08 delivery order to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg tablets (quantity 7s) under a firm fixed price contract, with an ultimate completion date of October 20, 2025. This non-set-aside award was competitively awarded and represents a direct delivery order leveraging AmerisourceBergen's existing federal contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ibrance 125 mg tablets in a quantity of seven units, with a ceiling value of $8,118.08. This firm fixed-price delivery order, which is expected to be completed by September 10, 2025, carries no set-aside designation and represents a competitively awarded transaction. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 25, 2025, with a ceiling value of $16,236.16 for the supply of Ibrance 125 mg capsules (21-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 17, 2025, and was awarded on a competitive basis without set-aside restrictions. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a $16,236.16 delivery order from the Defense Logistics Agency (DLA) on July 8, 2025, for 21 units of Ibrance 125 mg capsules, with completion targeted for July 29, 2025. This contract was awarded on a firm fixed price basis without a set-aside designation, indicating competitive award to the vendor. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $8,118.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg tablets on July 17, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, non-set-aside contract calls for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. This delivery...